Intra Cellular Therapies reported $2.12M in Interest Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Acadia Pharmaceuticals ACAD:US USD 2.3M 1.72M
BioCryst Pharmaceuticals BCRX:US USD 1.76M 1.15M
Biogen BIIB:US USD 23.9M 11.3M
Cytokinetics CYTK:US USD 4.14M 3.28M
Esperion Therapeutics ESPR:US USD 800K 400K
Intra Cellular Therapies ITCI:US USD 2.12M 802K
Jazz Pharmaceuticals JAZZ:US USD 3.5M 2.8M
Marinus Pharmaceuticals MRNS:US USD 514K 430K
Nektar Therapeutics NKTR:US USD 2.05M 954K
Prothena PRTA:US USD 1.91M 1.27M
Supernus Pharmaceuticals SUPN:US USD 2.8M 1.01M
United Therapeutics UTHR:US USD 13.3M 6.5M